WallStSmart

Kenvue Inc. (KVUE)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 4928% more annual revenue ($15.12B vs $300.79M). KVUE leads profitability with a 9.7% profit margin vs -3.2%. SKIN appears more attractively valued with a PEG of 0.95. KVUE earns a higher WallStSmart Score of 58/100 (C).

KVUE

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 8.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.22

SKIN

Hold

43

out of 100

Grade: D

Growth: 2.7Profit: 2.5Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUEUndervalued (+1.3%)

Margin of Safety

+1.3%

Fair Value

$18.79

Current Price

$17.66

$1.13 discount

UndervaluedFair: $18.79Overvalued

Intrinsic value data unavailable for SKIN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

SKIN2 strengths · Avg: 8.0/10
PEG RatioValuation
0.958/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

KVUE3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

SKIN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$148.22M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.2%3/10

Operating margin of 0.2%

Return on EquityProfitability
-16.9%2/10

ROE of -16.9% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bull Case : SKIN

The strongest argument for SKIN centers on PEG Ratio, Price/Book. PEG of 0.95 suggests the stock is reasonably priced for its growth.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Piotroski F-Score, Altman Z-Score.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

KVUE profiles as a value stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 1.21 — expect wider price swings.

KVUE is growing revenue faster at 3.2% — sustainability is the question.

KVUE generates stronger free cash flow (744M), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (58/100 vs 43/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?